72 related articles for article (PubMed ID: 30371623)
1. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C
J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623
[TBL] [Abstract][Full Text] [Related]
2. MRI Scoring Systems for Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q Codeletion in Adult-type Diffuse Glioma Lacking Contrast Enhancement.
Kang KM; Song J; Choi Y; Park C; Park JE; Kim HS; Park SH; Park CK; Choi SH
Radiology; 2024 May; 311(2):e233120. PubMed ID: 38713025
[TBL] [Abstract][Full Text] [Related]
3. A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas.
Qi P; Yao QL; Lao IW; Ren M; Bai QM; Cai X; Xue T; Wei R; Zhou XY
J Neuropathol Exp Neurol; 2024 Mar; 83(4):258-267. PubMed ID: 38408388
[TBL] [Abstract][Full Text] [Related]
4. 1p/19q testing has no significance in the workup of glioblastomas.
Clark KH; Villano JL; Nikiforova MN; Hamilton RL; Horbinski C
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):706-17. PubMed ID: 23363074
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
[TBL] [Abstract][Full Text] [Related]
6. Radiographic growth rate as a predictor of aggressiveness of diffuse gliomas without 1p19q codeletion.
Leclerc A; Roux A; Elia A; Peeters S; Aboubakr O; Bedioui A; Planet M; Benzakoun J; Simboli GA; Tauziede-Espariat A; Moiraghi A; Varlet P; Chrétien F; Oppenheim C; Zanello M; Pallud J
Neurosurg Focus; 2024 Feb; 56(2):E4. PubMed ID: 38301236
[TBL] [Abstract][Full Text] [Related]
7. Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
Jambor I; Steiner A; Pesola M; Gardberg M; Frantzén J; Jokinen P; Liimatainen T; Minn H; Aronen H; Merisaari H
PLoS One; 2024; 19(4):e0296958. PubMed ID: 38558074
[TBL] [Abstract][Full Text] [Related]
8. Is the anatomical distribution of low-grade gliomas linked to regions of gliogenesis?
Skjulsvik AJ; Bø HK; Jakola AS; Berntsen EM; Bø LE; Reinertsen I; Myrmel KS; Sjåvik K; Åberg K; Berg T; Dai HY; Kloster R; Torp SH; Solheim O
J Neurooncol; 2020 Mar; 147(1):147-157. PubMed ID: 31983026
[TBL] [Abstract][Full Text] [Related]
9. Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.
Hayashi S; Sasaki H; Kimura T; Abe T; Nakamura T; Kitamura Y; Miwa T; Kameyama K; Hirose Y; Yoshida K
Oncotarget; 2015 Jun; 6(18):15871-81. PubMed ID: 25991674
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostic testing of diffuse gliomas in the real-life setting: A practical approach.
Bieńkowski M; Wöhrer A; Moser P; Kitzwögerer M; Ricken G; Ströbel T; Hainfellner JA
Clin Neuropathol; 2018; 37(4):166-177. PubMed ID: 29923492
[TBL] [Abstract][Full Text] [Related]
11. Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification.
Olar A; Sulman EP
Semin Radiat Oncol; 2015 Jul; 25(3):155-63. PubMed ID: 26050585
[TBL] [Abstract][Full Text] [Related]
12. FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
Sharaf R; Pavlick DC; Frampton GM; Cooper M; Jenkins J; Danziger N; Haberberger J; Alexander BM; Cloughesy T; Yong WH; Liau LM; Nghiemphu PL; Ji M; Lai A; Ramkissoon SH; Albacker LA
Neurooncol Adv; 2021; 3(1):vdab017. PubMed ID: 33778493
[TBL] [Abstract][Full Text] [Related]
13. Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imaging.
Abecassis IJ; Cordy B; Durfy S; Andre JB; Levitt MR; Ellenbogen RG; Silbergeld DL; Ko AL
J Clin Neurosci; 2020 Jun; 76():46-52. PubMed ID: 32312627
[TBL] [Abstract][Full Text] [Related]
14. Transcranial Magnetic Stimulation-Based Machine Learning Prediction of Tumor Grading in Motor-Eloquent Gliomas.
Lavrador JP; Mirallave-Pescador A; Soumpasis C; Díaz Baamonde A; Aliaga-Arias J; Baig Mirza A; Patel S; David Siado Mosquera J; Gullan R; Ashkan K; Bhangoo R; Vergani F
Neurosurgery; 2024 Mar; ():. PubMed ID: 38511960
[TBL] [Abstract][Full Text] [Related]
15. Novel Imaging Approaches for Glioma Classification in the Era of the World Health Organization 2021 Update: A Scoping Review.
Richter V; Ernemann U; Bender B
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791871
[TBL] [Abstract][Full Text] [Related]
16. A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain.
Parisot S; Darlix A; Baumann C; Zouaoui S; Yordanova Y; Blonski M; Rigau V; Chemouny S; Taillandier L; Bauchet L; Duffau H; Paragios N
PLoS One; 2016; 11(1):e0144200. PubMed ID: 26751577
[TBL] [Abstract][Full Text] [Related]
17. Direct image to subtype prediction for brain tumors using deep learning.
Hewitt KJ; Löffler CML; Muti HS; Berghoff AS; Eisenlöffel C; van Treeck M; Carrero ZI; El Nahhas OSM; Veldhuizen GP; Weil S; Saldanha OL; Bejan L; Millner TO; Brandner S; Brückmann S; Kather JN
Neurooncol Adv; 2023; 5(1):vdad139. PubMed ID: 38106649
[TBL] [Abstract][Full Text] [Related]
18. Clinical Management of Diffuse Low-Grade Gliomas.
Lombardi G; Barresi V; Castellano A; Tabouret E; Pasqualetti F; Salvalaggio A; Cerretti G; Caccese M; Padovan M; Zagonel V; Ius T
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33081358
[TBL] [Abstract][Full Text] [Related]
19. Clear neuroimaging margin at the brain-tumor interface is associated with gross total resection and longer survival in non-enhancing diffuse gliomas.
Dharia AA; Gattozzi DA; Domino JS; Rouse AG; Chamoun RB
J Neurosurg Sci; 2024 May; ():. PubMed ID: 38814253
[TBL] [Abstract][Full Text] [Related]
20. A Visually Interpretable, Dictionary-Based Approach to Imaging-Genomic Modeling, With Low-Grade Glioma as a Case Study.
Kuthuru S; Deaderick W; Bai H; Su C; Vu T; Monga V; Rao A
Cancer Inform; 2018; 17():1176935118802796. PubMed ID: 30305794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
